Preparing stock dashboard...

Onconetix, Inc.

ONCO - NasdaqCM - Healthcare - Biotechnology

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Onconetix, Inc. trades as ONCO on NasdaqCM in the Healthcare sector and Biotechnology industry. Its latest stored price is $1.09 as of June 3, 2026.

Data updated June 3, 2026

Price
$1.09

Financial Snapshot

Metric Value ('000,000)

Stock Analysis

Scores this stock using the same metrics model as the compare page.

Metric Value Score

Price Chart

Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.

Drag window to pan. Drag edges to resize visible range.